Variations in the Cannabinoid Receptors and Migraines | cannabisMD

Variations in the Cannabinoid Receptors and Migraines

Cannabinoid receptor variations and migraine treatment

What Are The Symptoms of A Migraine?

Migraines are known as headache disorders. These are typically characterized by moderate to severe in terms of pain. Migraines often reoccur and usually, people who suffer from them develop them in early childhood, adolescence and early adulthood. People who experience headaches and migraines generally experience pulsating on one half of the head.

This experience can last anywhere from a few hours to 72 hours. Symptoms of a migraine may differ from person to person, however, there are also common symptoms and symptoms which also differ between the stages of the migraine. These stages are:

  1. Prodrome: (The Migraine is coming)
  2. Aura: (the feeling of the migraine)
  3. Attack: (Severe pain being caused)
  4. Post-drome: (the pain fading or going away)

Here is the full scientific article if you wish to download it.

Symptoms of thees stages vary, however some people who suffer from migraines don’t experience every stage. If you are experiencing any of the below symptoms, it’s important that you consult your doctor or a medical professional as they can help treat the symptoms and recommend the best treatment for you. Symptoms of a migraine includes:

  • Mood changes
  • Dizziness
  • Confusion
  • Loss of vision/blurred vision
  • Lightheadedness
  • Nausea
  • Vomiting
  • Sensitivity to light, sound and smell

Cannabiniod Receptors and Treating Migraines

In the susceptibility of a migraine. This effect to a certain extent is independent of related psychiatric co-morbidities, such as depression and substance abuse, suggesting that variation in the peripheral CB1 receptor function might be responsible for this association.

Further research is warranted to test how CNR1 exerts its effect on the development of migraine headaches and whether synthetic cannabinoids without central side effects are useful in migraine therapy. In addition, we provide the first evidence that using trait components combinations to identify extreme phenotypes and combined with haplotype analysis might be valuable in genetic association studies of a migraine.

Jonathan Neilly
Jonathan Neilly
Jonathan Neilly is registered with the British Psychological Society, breaking the taboo on mental health issues is one of the driving forces in his life. His background in biomedicine gives him additional understanding of the factors that work together to influence the human condition.

Leave a Reply

Your email address will not be published. Required fields are marked *